Kiovig (human normal immunoglobulin, IVIg) 30 g/300 mL, 1 vial, Takeda, original Kiovig is used as immunoglobulin replacement therapy for certain primary immunodeficiency syndromes. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.

Substitution therapy in adults, children and adolescents (0-18 years of age) in the following conditions:

• primary immunodeficiency syndrome (PID) with impaired antibody synthesis (see section "Particulars of use");
• secondary immunodeficiencies (SID) in patients with severe or recurrent infections, ineffective antimicrobial treatment,proven deficiency of specific antibodies (DNA)* or IgG level in blood serum < 4 g/l.

*DNAS - Inability to increase at least a two-fold increase in the titer of IgG antibodies to the pneumococcal polysaccharide vaccine and polypeptide antigen.

Immunomodulation in adults, children and adolescents (age 0?18 years) in the following conditions:

• primary immune thrombocytopenia (ITP) in patients with a high risk of bleeding or before surgery to correct the platelet count;
• Guyen's syndrome? Barre;
• Kawasaki disease (in combination with acetylsalicylic acid, see section "Method of use and dosage");
• chronic inflammatory demyelinating polyradiculoneuropathy (CPD);
• multifocal motor neuropathy (BMN).